Survival times of cats with hyperthyroidism treated with thyroidectomy or methimazole
Feline hyperthyroidism (FHT) is the most common endocrine disease in elderly cats, with a reported prevalence of up to 10% in cats aged > 10 years. If left untreated, cats with hyperthyroidism can develop life-threatening thyrotoxicosis. This study identified the associated factors and compared the survival times of feline hyperthyroidism (FHT) between thyroidectomy and methimazole alone.
The medical records of 41 cats diagnosed with new-onset hyperthyroidism were retrospectively reviewed. The cats were categorized into the thyroidectomy (n = 15) and methimazole (26) treatment groups. Survival analyses using the Kaplan-Meier method, log-rank test, and Cox proportional hazards models were conducted to compare the time to the selected outcomes.
Univariate analysis revealed that survival time was significantly longer with thyroidectomy than with methimazole (P < .001). Multivariate analyses revealed thyroidectomy as an independent prognostic factor for good outcomes (hazard ratio, 0.209; 95% CI, 0.073 to 0.601; P = .004). The recurrence rate was significantly lower in cats that underwent thyroidectomy than in those that received methimazole alone (P = .011).
Compared with methimazole alone, thyroidectomy was associated with a longer survival time in FHT and can be considered an irreversible treatment modality in settings where radioisotopes are not available.
“Comparison of survival times of cats with hyperthyroidism treated with thyroidectomy or methimazole at a primary care hospital in Japan”. Eiji Naito, et al. J Am Vet Med Assoc. 2024 Jul 17:1-7.
Source: https://avmajournals.avma.org/view/journals/javma/aop/javma.24.01.0057/javma.24.01.0057.xml
Comments
Related Articles
More news
.jpg)
Copyright © 2026 - All Rights Reserved
ISSN 2768-198X
List
Add
Please enter a comment